Taiho Pharmaceutical and Phost’in Therapeutics announce an Option and License Agreement on the First-in-Class GnT-V inhibitor PhOx430
Montpellier, France – August 2023, 25th
Montpellier, France – August 2023, 25th
Montpellier, France – Mars 2022, 09th
Montpellier, France – June 2020, 17th
Montpellier, France – April 2020, 20th